Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism CRHR1 antagonists(Corticotropin-releasing factor receptor 1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H31N3O3 |
InChIKeyVVOKUTLMKHSKLC-UHFFFAOYSA-N |
CAS Registry186342-55-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Phase 1 | - | - | |
Anxiety Disorders | Phase 1 | United States | - | |
Depressive Disorder, Major | Phase 1 | United States | - |